Institutional investors hold a majority ownership of TEVA through the 59.31% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Generic industry. Last, during the quarter ended March 2016, these large investors purchased a net $10.1 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
VIKING GLOBAL INVESTORS LP Bought 7.9 Million shares of Teva Pharmaceutical
NORDEA INVESTMENT MANAGEMENT AB ... Bought 5.7 Million shares of Teva Pharmaceutical
OZ MANAGEMENT LP Bought 4.9 Million shares of Teva Pharmaceutical